Tenders Are Invited For Pharmaceutical Products - Zp/Czd/052/26 Supply Of Medicinal Products And Provision Of Repackaging And Labeling Services For Medicinal Products Containing Everolimus, Together With Their Release For Use In The Non-Commercial Medway Clinical Trial Phase I Study On The Use Of The Cdk8 Inhibitor Rvu120 In Combination With Everolimus In Children With Recurrent Or Progressive Group 3 Or 4 Medulloblastoma
Tenders Are Invited For Pharmaceutical Products - Zp/Czd/052/26 Supply Of Medicinal Products And Provision Of Repackaging And Labeling Services For Medicinal Products Containing Everolimus, Together With Their Release For Use In The Non-Commercial Medway Clinical Trial Phase I Study On The Use Of The Cdk8 Inhibitor Rvu120 In Combination With Everolimus In Children With Recurrent Or Progressive Group 3 Or 4 Medulloblastoma
Pharmaceutical Products - Zp/Czd/052/26 Supply Of Medicinal Products And Provision Of Repackaging And Labeling Services For Medicinal Products Containing Everolimus, Together With Their Release For Use In The Non-Commercial Medway Clinical Trial Phase I Study On The Use Of The Cdk8 Inhibitor Rvu120 In Combination With Everolimus In Children With Recurrent Or Progressive Group 3 Or 4 Medulloblastoma. Package 1 - Everolimus 0.5 Mg,Package 2 - Everolimus 2.5 Mg,Package 3 - Everolimus 5 Mg,Package 4 - Repackaging, Labeling And Release Of Medicinal Products For Use Service,Package 5 - Aprepitant 125Mg + 80Mg,Package 6 - Ondansetron 4 Mg,Package 7 - Dexamethasone 8 Mg
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
